Skip to content

The Effect of Dry Needling in Patients With Knee Osteoarthritis

The Effect of One Dry Needling Session on Pain and Central Pain Processing in Patients With Knee Osteoarthritis: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04717167
Enrollment
61
Registered
2021-01-20
Start date
2016-12-01
Completion date
2019-04-01
Last updated
2021-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Knee

Keywords

dry needling, central pain processing, pain, EMG measurements, muscle coactivation, gait pattern

Brief summary

Research suggests that myofascial trigger points (MTrP) play an important role in explaining pain in patients with musculoskeletal knee disorders. Trigger points are usually defined as hypersensitive tender spots within taut bands of skeletal muscles that are painful on muscle stimulation and that usually elicit referred pain. Treatment of these trigger points could possibly alleviate symptoms in patients with knee pain. However, literature on the effect of trigger point therapy, dry needling in particular, in patients with musculoskeletal knee disorders is scarce. The purpose of this study is to examine the effect of trigger point therapy (dry needling (DN)) on pain, presence of altered central pain processing, muscle features and gait pattern in patients with knee osteoarthritis (KOA). 60 patients with symptomatic KOA will participate in this study. They will randomly be allocated in either an experimental group (EG) (dry needling technique) or a placebo group (PG) (sham needling technique). Pain (Visual analogue scale (VAS) & KOA outcome score (KOOS), muscle features during gait and gait pattern (3D gait analysis and surface electroMyoGraphy (EMG)) and presence of altered central pain processing (Central Sensitization Inventory (CSI), Quantitative Sensory testing (QST)) will be measured at baseline and 15 minutes after the intervention. Additionally, pain will be measured 3 days after the intervention. The investigators hypothesize that the effect on the outcome measures will be significantly larger in the EG compared to the PG.

Interventions

OTHERDry Needling

Sponsors

Universiteit Antwerpen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

A double-blinded study was achieved by giving no information about the assigned intervention to the executive researchers; and only the same general explanation about the intervention type to the subjects (Appendix A). Moreover, subjects were prohibited to see the needling-intervention. The group allocation was solely known by the treating therapists and the independent researcher (IB).

Intervention model description

One group will receive dry needling session and one group will receive placebo treatment. A simple randomization on a website (www.randomizer.org) performed by a researcher (IB), independent from the executive researchers.

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* A minimum age of fifty years old; * Diagnosed with KOA based on the American College of Rheumatology (ACR) clinical classification criteria(48), including: * A Kellgren-Lawrence grade of minimum two on radiography; * At least three months of chronical knee pain.

Exclusion criteria

* Patients suffering from autoimmune and/or neurological disorders * Patients who had a major trauma/fracture of the lower limb in the past six months - * Patients who experienced other musculoskeletal problems than OA

Design outcomes

Primary

MeasureTime frameDescription
Pain sensationChange from baseline pain sensation at 15minutes postinterventionMeasured with a Visual Analogue Scale, scored from 0 to 100, where higher scores indicate higher pain sensation.
Pain pressure thresholdsChange from baseline central pain processing at 15minutes postinterventionMeasured with an digital algometer (kilogram force/ square cm)
Temporal summationChange from baseline central pain processing at 15minutes postinterventionMeasured with an digital algometer (kilogram force/ square cm)
Conditioned pain modulationChange from baseline central pain processing at 15minutes postinterventionMeasured with an digital algometer (test stimulus) and an inflatable cuff (conditioning stimulus). (kilogram force/ square cm)

Secondary

MeasureTime frameDescription
Muscle coactivation of musculus Tibialis anterior and musculus Gastrocnemius medialisChange from baseline muscle coactivation at 15minutes postinterventionMeasured with wireless surface electromyography. Muscle activation patterns will be gathered through surface electrodes. Hereafter, the co-contraction index was calculated. Higher percentages indicate higher coactivation.
Muscle coactivation of musculus Tibialis anterior and musculus Gastrocnemius lateralisChange from baseline muscle coactivation at 15minutes postinterventionMeasured with wireless surface electromyography. Muscle activation patterns will be gathered through surface electrodes. Hereafter, the co-contraction index was calculated. Higher percentages indicate higher coactivation.
Stride time (seconds)Change from baseline muscle coactivation at 15minutes postinterventionmeasured with force plates and markers to measure toe off and heel strike during a 3D motion analysis.
Stride length (meters)Change from baseline muscle coactivation at 15minutes postinterventionmeasured with force plates and markers to measure toe off and heel strike during a 3D motion analysis.
Muscle coactivation of musculus Vastus lateralis and musculus Biceps femorisChange from baseline muscle coactivation at 15minutes postinterventionMeasured with wireless surface electromyography. Muscle activation patterns will be gathered through surface electrodes. Hereafter, the co-contraction index was calculated. Higher percentages indicate higher coactivation.
Stance phase (%)Change from baseline muscle coactivation at 15minutes postinterventionmeasured with force plates and markers to measure toe off and heel strike during a 3D motion analysis.
Step length (meters)Change from baseline muscle coactivation at 15minutes postinterventionmeasured with force plates and markers to measure toe off and heel strike during a 3D motion analysis.
Step width (meters)Change from baseline muscle coactivation at 15minutes postinterventionmeasured with force plates and markers to measure toe off and heel strike during a 3D motion analysis.
Step time (meters/second)Change from baseline muscle coactivation at 15minutes postinterventionmeasured with force plates and markers to measure toe off and heel strike during a 3D motion analysis.
Muscle coactivation of musculus Vastus medialis and musculus SemitendinosusChange from baseline muscle coactivation at 15minutes postinterventionMeasured with wireless surface electromyography. Muscle activation patterns will be gathered through surface electrodes. Hereafter, the co-contraction index was calculated. Higher percentages indicate higher coactivation.
Muscle coactivation of musculus Vastus medialis and musculus Biceps femorisChange from baseline muscle coactivation at 15minutes postinterventionMeasured with wireless surface electromyography. Muscle activation patterns will be gathered through surface electrodes. Hereafter, the co-contraction index was calculated. Higher percentages indicate higher coactivation.
Muscle coactivation of musculus Vastus lateralis and musculus SemitendinosusChange from baseline muscle coactivation at 15minutes postinterventionMeasured with wireless surface electromyography. Muscle activation patterns will be gathered through surface electrodes. Hereafter, the co-contraction index was calculated. Higher percentages indicate higher coactivation.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026